PREVENT HPV Cancers Act of 2023

I 118TH CONGRESS 1ST SESSION H. R. 3633 To amend the Public Health Service Act to provide for a public awareness campaign with respect to human papillomavirus, and for other purposes. IN THE HOUSE OF REPRESENTATIVES MAY 24, 2023 Ms. CASTOR of Florida (for herself, Ms. LETLOW, and Ms. SCHRIER) intro- duced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Public Health Service Act to provide for a public awareness campaign with respect to human papillomavirus, and for other purposes. Be it enacted by the Senate and House of Representa- 1 tives of the United States of America in Congress assembled, 2 SECTION 1. SHORT TITLE. 3 This Act may be cited as the ‘‘Promoting Resources 4 to Expand Vaccination, Education and New Treatments 5 for HPV Cancers Act of 2023’’ or the ‘‘PREVENT HPV 6 Cancers Act of 2023’’. 7 SEC. 2. FINDINGS. 8 Congress finds the following: 9 VerDate Sep 11 2014 23:05 Jun 15, 2023 Jkt 039200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H3633.IH H3633 pbinns on DSKJLVW7X2PROD with $$_JOB 2 •HR 3633 IH (1) The human papillomavirus (referred to in 1 this Act as ‘‘HPV’’) causes six different types of 2 cancer (anal, cervical, oropharynx, penile, vaginal, 3 and vulvar). 4 (2) Approximately 37,300 cases of cancer are 5 caused by HPV each year impacting both women 6 and men. 7 (3) About 90 percent of cervical and anal can- 8 cers are thought to be caused by HPV. 9 (4) Black and Hispanic women are more likely 10 to get HPV-associated cervical cancer than women 11 of other races and ethnicities due to disparities in 12 access to cancer screening and early detection. 13 (5) New cases of cervical cancer decreased 14 among women in young age groups, likely due to 15 HPV vaccination, but in recent years, new cases of 16 cervical cancer rates among women in older age 17 groups have plateaued or, in the case of women ages 18 30–34, increased. 19 (6) Cervical cancer screening has declined and 20 there has been an increase in cervical cancer diag- 21 nosed at distant stages, which are more difficult to 22 treat and more likely to recur, leading to greater 23 morbidity and mortality. 24 VerDate Sep 11 2014 23:05 Jun 15, 2023 Jkt 039200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H3633.IH H3633 pbinns on DSKJLVW7X2PROD with $$_JOB 3 •HR 3633 IH (7) Approximately 60 to 70 percent of 1 oropharynx cancer is tied to HPV. 2 (8) Most HPV infections that can lead to can- 3 cer can be prevented by vaccines. 4 (9) HPV vaccines can also help prevent recur- 5 rent respiratory papillomatosis, anal and genital 6 warts. 7 (10) Vaccination for HPV is approved for men 8 and women. 9 (11) The vaccines are most effective if adminis- 10 tered when an individual is between the ages of 9 11 and 17. 12 (12) Approximately 60 percent of adolescents 13 have completed the HPV vaccine series. 14 (13) Adolescents living in rural areas continue 15 to be less likely to have initiated and completed the 16 HPV vaccine series than those living in urban areas. 17 (14) Health providers’ recommendation of the 18 vaccine is critical to getting adolescents vaccinated. 19 SEC. 3. HPV VACCINE PUBLIC AWARENESS CAMPAIGN. 20 (a) IN GENERAL.—Section 317 of the Public Health 21 Service Act (42 U.S.C. 247b) is amended by adding at 22 the end the following new subsection: 23 ‘‘(o) HPV VACCINE PUBLIC AWARENESS CAM- 24 PAIGN.— 25 VerDate Sep 11 2014 23:05 Jun 15, 2023 Jkt 039200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H3633.IH H3633 pbinns on DSKJLVW7X2PROD with $$_JOB 4 •HR 3633 IH ‘‘(1) IN GENERAL.—The Secretary, acting 1 through the Director of the Centers for Disease 2 Control and Prevention, shall carry out a national 3 campaign to— 4 ‘‘(A) increase awareness of the importance 5 of HPV vaccination; 6 ‘‘(B) combat misinformation about HPV 7 vaccination; and 8 ‘‘(C) increase HPV vaccination rates and 9 completion of the vaccine series, especially 10 among males. 11 ‘‘(2) CONSULTATION.—In carrying out the na- 12 tional campaign required by paragraph (1), the Sec- 13 retary shall consult with the National Academy of 14 Medicine, including health care providers and public 15 health associations, nonprofit organizations (includ- 16 ing those that represent communities most impacted 17 by HPV-associated cancers and communities with 18 low vaccination rates), State and local public health 19 departments, elementary and secondary education 20 organizations (including student and parent organi- 21 zations), and institutions of higher education, to so- 22 licit advice on evidence-based information for policy 23 development and program development, implementa- 24 tion, and evaluation. 25 VerDate Sep 11 2014 23:05 Jun 15, 2023 Jkt 039200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H3633.IH H3633 pbinns on DSKJLVW7X2PROD with $$_JOB 5 •HR 3633 IH ‘‘(3) REQUIREMENTS.—The national campaign 1 required by paragraph (1) shall— 2 ‘‘(A) include the use of evidence-based 3 media and public engagement; 4 ‘‘(B) be carried out through competitive 5 grants or cooperative agreements awarded to 1 6 or more private, nonprofit entities with a his- 7 tory developing and implementing similar cam- 8 paigns; 9 ‘‘(C) include the development of culturally 10 and linguistically competent resources that shall 11 be tailored for— 12 ‘‘(i) communities with high rates of— 13 ‘‘(I) unvaccinated individuals, in- 14 cluding males; 15 ‘‘(II) individuals with unique 16 health care needs (such as lesbian, 17 gay, bisexual, transgender, and queer 18 individuals); 19 ‘‘(III) individuals with high rates 20 of cervical cancer and other HPV-as- 21 sociated cancers (such as Black and 22 Hispanic women); and 23 ‘‘(IV) populations impacted by 24 the increase in oropharynx cancers; 25 VerDate Sep 11 2014 23:05 Jun 15, 2023 Jkt 039200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\H3633.IH H3633 pbinns on DSKJLVW7X2PROD with $$_JOB 6 •HR 3633 IH ‘‘(ii) rural communities; and 1 ‘‘(iii) such other communities as the 2 Secretary determines appropriate; 3 ‘‘(D) include the dissemination of HPV 4 vaccination information and communication re- 5 sources to health care providers and health care 6 facilities (including primary care providers, 7 community health centers, dentists, obstetri- 8 cians, and gynecologists), and such providers 9 and such facilities for pediatric care, State and 10 local public health departments, elementary and 11 secondary schools, and colleges and universities; 12 ‘‘(E) be complementary to, and coordi- 13 nated with, any other Federal efforts with re- 14 spect to HPV vaccination; 15 ‘‘(F) include message testing to identify 16 culturally competent and effective messages for 17 behavioral change; and 18 ‘‘(G) include the award of grants or coop- 19 erative agreements to State, local, and Tribal 20 public health departments— 21 ‘‘(i) to engage with communities speci- 22 fied in subparagraph (C), local education 23 agencies, health care providers, community 24 organizations, or other groups the Sec- 25 VerDate Sep 11 2014 23:05 Jun 15, 2023 Jkt 039200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\H3633.IH H3633 pbinns on DSKJLVW7X2PROD with $$_JOB 7 •HR 3633 IH retary determines are appropriate to de- 1 velop and deliver effective strategies to in- 2 crease HPV vaccination rates; and 3 ‘‘(ii) to disseminate culturally and lin- 4 guistically competent resources on the Na- 5 tional Breast and Cervical Cancer Early 6 Detection Program and where an indi- 7 vidual can access the screenings locally. 8 ‘‘(4) OPTIONS FOR DISSEMINATION OF INFOR- 9 MATION.—The national campaign required by para- 10 graph (1) may— 11 ‘‘(A) include the use of— 12 ‘‘(i) social media, television, radio, 13 print, the internet, and other media; 14 ‘‘(ii) in-person or virtual public com- 15 munications; and 16 ‘‘(iii) recognized, trusted figures; 17 ‘‘(B) be targeted to specific groups and 18 communities specified in paragraph (3)(C); and 19 ‘‘(C) include the dissemination of informa- 20 tion highlighting each of the following: 21 ‘‘(i) Recommended age range to get 22 the HPV vaccine. 23 VerDate Sep 11 2014 02:41 Jun 16, 2023 Jkt 039200 PO 00000 Frm 00007 Fmt 6652 Sfmt 6201 E:\BILLS\H3633.IH H3633 pbinns on DSKJLVW7X2PROD with $$_JOB 8 •HR 3633 IH ‘‘(ii) The benefits of getting vac- 1 cinated against HPV, including the poten- 2 tial to not acquire HPV-associated cancers. 3 ‘‘(iii) HPV vaccine safety and the sys- 4 tems in place to monitor such safety. 5 ‘‘(5) AUTHORIZATION OF APPROPRIATIONS.— 6 There is authorized to be appropriated to carry out 7 this subsection $5,000,000 for each of fiscal years 8 2024 through 2028.’’. 9 (b) REPORT TO CONGRESS.—Not later than 2025, 10 the Secretary of Health and Human Services shall submit 11 to the Committee on Energy and Commerce of the House 12 of Representatives and the Committee on Health, Edu- 13 cation, Labor and Pensions of the Senate a report— 14 (1) that contains a qualitative assessment of 15 the campaign under subsection (o) of section 317 of 16 the Public Health Service Act (42 U.S.C. 247b), as 17 added by subsection (a), and the activities conducted 18 under such campaign; and 19 (2) on, with respect to the impact on cancer as- 20 sociated with human papillomavirus, the activities 21 conducted under such subsection (o). 22 VerDate Sep 11 2014 23:05 Jun 15, 2023 Jkt 039200 PO 00000 Frm 00008 Fmt 6652 Sfmt 6201 E:\BILLS\H3633.IH H3633 pbinns on DSKJLVW7X2PROD with $$_JOB 9 •HR 3633 IH SEC. 4. BREAST AND CERVICAL CANCER EARLY DETECTION 1 PROGRAM. 2 (a) IN GENERAL.—Section 1510(a) of the Public 3 Health Service Act (42 U.S.C. 300n–5(a)) is amended by 4 striking ‘‘and $275,000,000 for fiscal year 2012’’ and in- 5 serting ‘‘$275,000,000 for fiscal year 2012, and 6 $300,000,000 for each fiscal years 2024 through 2028’’. 7 (b) COORDINATING COMMITTEE.—Section 1501(d) of 8 the Public Health Service Act (42 U.S.C. 300k(d)) is 9 amended— 10 (1) in the subsection heading, by striking 11 ‘‘2020’’ and inserting ‘‘2030’’; and 12 (2) by striking ‘‘2020’’ and inserting ‘‘2025’’. 13 Æ VerDate Sep 11 2014 23:05 Jun 15, 2023 Jkt 039200 PO 00000 Frm 00009 Fmt 6652 Sfmt 6301 E:\BILLS\H3633.IH H3633 pbinns on DSKJLVW7X2PROD with $$_JOB